Events

Immunoengineered Platforms for Type 1 Diabetes

10/07/2024, 3:00 pm - 4:00 pm

Destruction of insulin-producing beta cells by beta cell autoreactive T cells in patients with type 1 diabetes leads to dependency on exogenous insulin injections to regulate glycemia. However, proper metabolic control is often not achieved, and long-term severe complications occur. Beta cell replacement improves metabolic control and quality of life in patients with severe type...
READ MORE
Communicore, C1-15, Gainesville, FL

1 2